• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超声造影剂 SonoVue 靶向递送 Salusin-α 至兔颈总动脉内皮。

Targeted Delivery of Salusin-α Into Rabbit Carotid Arterial Endothelium Using SonoVue.

机构信息

Department of Laboratory Medicine, Hubei University of Chinese Medicine, Wuhan, China.

Central Laboratory, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

出版信息

J Ultrasound Med. 2022 Feb;41(2):365-376. doi: 10.1002/jum.15714. Epub 2021 Apr 5.

DOI:10.1002/jum.15714
PMID:33818784
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9291317/
Abstract

OBJECTIVES

A new method based on the adhesion of SonoVue to plasmids was assessed to achieve targeted gene delivery into the vascular endothelium.

METHODS

pEGFP-Salusin-α and pcDNA3.1-Salusin-α plasmids were transfected into the arterial endothelium of different rabbit groups. Western blotting was performed to analyze the expression of EGFP and salusin-α in the common carotid arteries of rabbits from different groups, and ELISA was performed to detect plasma salusin-α levels in rabbits from each group; simultaneously, blood parameters of different groups of rabbits were measured.

RESULTS

Green fluorescence was observed in the right common carotid artery of rabbits transfected with pEGFP-Salusin-α, but not in the endothelial cells of not-transfected control rabbits. The expression of salusin-α in the transfected animals was higher than that in the control not-transfected animals (P < .05). In rabbits transfected with pcDNA3.1-Salusin-α plasmid, salusin-α expression was higher than in the not-transfected control animals (P < .05). However, there was no significant difference in plasma salusin-α levels between transfected animals and controls (P > .05). Blood parameters were also measured in both groups.

CONCLUSIONS

Our data confirm the establishment of a new method using SonoVue for targeted gene delivery into the arterial endothelium. Our study outcomes propose a new method of intervention in atherosclerosis and a new tool for targeted gene delivery.

摘要

目的

评估一种基于 SonoVue 与质粒结合的新方法,以实现血管内皮的靶向基因传递。

方法

将 pEGFP-Salusin-α 和 pcDNA3.1-Salusin-α 质粒转染到不同兔组的动脉内皮中。通过 Western blot 分析不同组兔颈总动脉中 EGFP 和 salusin-α 的表达,通过 ELISA 检测各组兔血浆 salusin-α 水平;同时,测量各组兔的血液参数。

结果

转染 pEGFP-Salusin-α 的兔右侧颈总动脉可见绿色荧光,但未转染对照组兔的内皮细胞未见荧光。转染动物的 salusin-α 表达高于未转染对照组动物(P<.05)。转染 pcDNA3.1-Salusin-α 质粒的兔 salusin-α 表达高于未转染对照组动物(P<.05)。然而,转染动物与对照组之间的血浆 salusin-α 水平无显著差异(P>.05)。两组均测量了血液参数。

结论

我们的数据证实了使用 SonoVue 靶向基因传递到动脉内皮的新方法的建立。我们的研究结果提出了一种新的干预动脉粥样硬化的方法和一种新的靶向基因传递工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8433/9291317/cec3bbe5c242/JUM-41-365-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8433/9291317/3119baa738cc/JUM-41-365-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8433/9291317/2dc28da890d9/JUM-41-365-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8433/9291317/a3d62e1ad64c/JUM-41-365-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8433/9291317/3f4d6baa34f3/JUM-41-365-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8433/9291317/cec3bbe5c242/JUM-41-365-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8433/9291317/3119baa738cc/JUM-41-365-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8433/9291317/2dc28da890d9/JUM-41-365-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8433/9291317/a3d62e1ad64c/JUM-41-365-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8433/9291317/3f4d6baa34f3/JUM-41-365-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8433/9291317/cec3bbe5c242/JUM-41-365-g003.jpg

相似文献

1
Targeted Delivery of Salusin-α Into Rabbit Carotid Arterial Endothelium Using SonoVue.超声造影剂 SonoVue 靶向递送 Salusin-α 至兔颈总动脉内皮。
J Ultrasound Med. 2022 Feb;41(2):365-376. doi: 10.1002/jum.15714. Epub 2021 Apr 5.
2
Overexpression of Salusin- Inhibits Vascular Intimal Hyperplasia in an Atherosclerotic Rabbit Model.Salusin-α 过表达抑制动脉粥样硬化兔模型血管内膜增生。
Biomed Res Int. 2018 Jul 12;2018:8973986. doi: 10.1155/2018/8973986. eCollection 2018.
3
Salusin-α Inhibits Proliferation and Migration of Vascular Smooth Muscle Cell via Akt/mTOR Signaling.Salusin-α通过Akt/mTOR信号通路抑制血管平滑肌细胞的增殖和迁移。
Cell Physiol Biochem. 2018;50(5):1740-1753. doi: 10.1159/000494792. Epub 2018 Nov 1.
4
Serum salusin-alpha levels are decreased and correlated negatively with carotid atherosclerosis in essential hypertensive patients.原发性高血压患者血清salusin-α水平降低,且与颈动脉粥样硬化呈负相关。
Hypertens Res. 2008 Mar;31(3):463-8. doi: 10.1291/hypres.31.463.
5
Relationship of salusin-alpha and salusin-beta levels with atherosclerosis in patients undergoing haemodialysis.血液透析患者中 salusin-α 和 salusin-β 水平与动脉粥样硬化的关系。
Singapore Med J. 2019 Apr;60(4):210-215. doi: 10.11622/smedj.2018123. Epub 2018 Oct 10.
6
Associations of serum salusin-alpha levels with atherosclerosis and left ventricular diastolic dysfunction in essential hypertension.血清 salusin-α 水平与原发性高血压患者动脉粥样硬化及左心室舒张功能障碍的相关性。
J Hum Hypertens. 2012 Oct;26(10):603-9. doi: 10.1038/jhh.2011.71. Epub 2011 Aug 11.
7
Salusin-α Attenuates Inflammatory Responses in Vascular Endothelial Cells.Salusin-α减轻血管内皮细胞中的炎症反应。
Biochemistry (Mosc). 2017 Nov;82(11):1314-1323. doi: 10.1134/S0006297917110098.
8
Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulator.人血清素-β的循环水平,一种有效的血流动力学和动脉粥样形成调节剂。
PLoS One. 2013 Oct 3;8(10):e76714. doi: 10.1371/journal.pone.0076714. eCollection 2013.
9
The importance of circulating levels of salusin-α, salusin-β, and heregulin-β1 in atherosclerotic coronary arterial disease.循环水平的 salusin-α、salusin-β 和 heregulin-β1 在动脉粥样硬化性冠状动脉疾病中的重要性。
Clin Biochem. 2021 Jan;87:19-25. doi: 10.1016/j.clinbiochem.2020.10.003. Epub 2020 Oct 5.
10
Serum salusin-alpha level in rheumatoid arthritis.类风湿关节炎患者血清中Salusin-α水平
Regul Pept. 2011 Feb 25;167(1):125-8. doi: 10.1016/j.regpep.2010.12.003. Epub 2010 Dec 24.

引用本文的文献

1
Salusin‑α alleviates lipid metabolism disorders via regulation of the downstream lipogenesis genes through the LKB1/AMPK pathway.Salusin-α 通过 LKB1/AMPK 通路调节下游脂肪生成基因来缓解脂质代谢紊乱。
Int J Mol Med. 2024 Sep;54(3). doi: 10.3892/ijmm.2024.5397. Epub 2024 Jul 4.

本文引用的文献

1
Coronary artery bypass surgery plus medical therapy versus medical therapy alone for ischaemic heart disease: a protocol for a systematic review with meta-analysis and trial sequential analysis.冠状动脉旁路移植手术联合药物治疗与单纯药物治疗用于缺血性心脏病的系统评价与荟萃分析及试验序贯分析方案。
Syst Rev. 2019 Oct 28;8(1):246. doi: 10.1186/s13643-019-1155-9.
2
Disparities in Secondary Prevention of Atherosclerotic Heart Disease After Coronary Artery Bypass Grafting in Northern Plains American Indians.美国北部平原印第安人冠状动脉搭桥术后动脉粥样硬化性心脏病二级预防的差异
Health Equity. 2019 Oct 24;3(1):520-526. doi: 10.1089/heq.2019.0030. eCollection 2019.
3
Long-term (10-year) outcomes of stenting or bypass surgery for acute coronary syndromes and stable ischemic heart disease with unprotected left main coronary artery disease.
无保护左主干病变的急性冠状动脉综合征和稳定型缺血性心脏病患者行支架置入术或旁路手术的 10 年长期结局。
Am Heart J. 2019 Dec;218:9-19. doi: 10.1016/j.ahj.2019.08.014. Epub 2019 Aug 20.
4
[Efficacy and safety of the drug mexidol FORTE 250 as part of sequential therapy in patients with chronic ischemia of the brain].
Zh Nevrol Psikhiatr Im S S Korsakova. 2019;119(9):39-45. doi: 10.17116/jnevro201911909139.
5
Interpreting stimulated plasma renin and aldosterone to select physiologically individualized therapy for resistant hypertension: importance of the class of stimulating drugs.解读刺激后的血浆肾素和醛固酮以选择抵抗性高血压的生理性个体化治疗:刺激药物类别的重要性。
Hypertens Res. 2019 Dec;42(12):1971-1978. doi: 10.1038/s41440-019-0327-2. Epub 2019 Sep 27.
6
A Theranostic Cathepsin Activity-Based Probe for Noninvasive Intervention in Cardiovascular Diseases.一种用于心血管疾病非侵入性干预的治疗性组织蛋白酶活性探针。
Theranostics. 2019 Aug 12;9(20):5731-5738. doi: 10.7150/thno.34402. eCollection 2019.
7
The challenge of multiple cardiovascular risk factor control outside Western Europe: Findings from the International ChoLesterol management Practice Study.多重心血管风险因素控制在西欧以外地区面临的挑战:来自国际胆固醇管理实践研究的发现。
Eur J Prev Cardiol. 2020 Sep;27(13):1403-1411. doi: 10.1177/2047487319871735. Epub 2019 Sep 19.
8
Lipoprotein(a) as a key target in combined therapeutic approaches for cardiovascular disease.脂蛋白(a)作为心血管疾病联合治疗方法中的关键靶点。
Rev Port Cardiol (Engl Ed). 2019 Jul;38(7):485-493. doi: 10.1016/j.repc.2019.01.006. Epub 2019 Sep 15.
9
Clinical outcomes and complications of treatment with supraflex stent in patients with coronary artery disease: One-year follow-up.冠状动脉疾病患者使用Supraflex支架治疗的临床结果及并发症:一年随访
Eur J Transl Myol. 2019 May 22;29(2):8231. doi: 10.4081/ejtm.2019.8231. eCollection 2019 May 7.
10
Overexpression of Salusin- Inhibits Vascular Intimal Hyperplasia in an Atherosclerotic Rabbit Model.Salusin-α 过表达抑制动脉粥样硬化兔模型血管内膜增生。
Biomed Res Int. 2018 Jul 12;2018:8973986. doi: 10.1155/2018/8973986. eCollection 2018.